Michael Fleming was appointed President of the Delaware BioScience Association in June 2020. Prior to joining Delaware Bio, he spent 18 years at the global biopharmaceutical company GlaxoSmithKline (GSK), most recently as Head of Global Medical and Regulatory Communications. During his time at GSK he also led corporate brand management, US CSR and community investment, digital media and product communications, and was president of the GlaxoSmithKline Foundation. Earlier he held positions in strategy, marketing and public affairs at GD Searle and DuPont Pharmaceuticals.
Fleming began his career as an aide to the late United States Senator William V. Roth, Jr., first as a legislative assistant on Capitol Hill and then as the senator’s Wilmington state office director. He is a graduate of the Johns Hopkins School of Advanced International Studies and the University of Delaware. Michael and his family live in Wilmington.